TALIS BIOMEDICAL CORP's ticker is TLIS and the CUSIP is 87424L108. A total of 48 filers reported holding TALIS BIOMEDICAL CORP in Q4 2021. The put-call ratio across all filers is 2.03 and the average weighting 0.0%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2023 | $751 | -2.0% | 1,564 | 0.0% | 0.00% | – |
Q1 2023 | $766 | – | 1,564 | 0.0% | 0.00% | – |
Q4 2022 | $0 | -100.0% | 1,564 | -21.8% | 0.00% | – |
Q3 2022 | $2,000 | 0.0% | 2,000 | 0.0% | 0.00% | – |
Q2 2022 | $2,000 | 0.0% | 2,000 | 0.0% | 0.00% | – |
Q1 2022 | $2,000 | -77.8% | 2,000 | -7.0% | 0.00% | – |
Q4 2021 | $9,000 | -30.8% | 2,150 | 0.0% | 0.00% | – |
Q3 2021 | $13,000 | 0.0% | 2,150 | +87.0% | 0.00% | – |
Q2 2021 | $13,000 | -13.3% | 1,150 | 0.0% | 0.00% | – |
Q1 2021 | $15,000 | – | 1,150 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|